World's Best Scientists 2026 revealed!

D-Index & Metrics

Molecular Biology

D-Index
65
Citations
13122
World Ranking
1683
National Ranking
850

Pulivarthi H. Rao publication distribution in Molecular Biology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Molecular Biology in 2026. The highlighted bar marks where Pulivarthi H. Rao sits on this spectrum.

47–56 publications: 7 scientists 57–66 publications: 17 scientists 67–76 publications: 65 scientists 77–86 publications: 90 scientists 87–96 publications: 125 scientists 97–106 publications: 131 scientists 107–116 publications: 162 scientists 117–126 publications: 177 scientists 127–136 publications: 158 scientists 137–146 publications: 158 scientists 147–156 publications: 146 scientists 157–166 publications: 159 scientists 167–176 publications: 131 scientists 177–186 publications: 110 scientists 187–196 publications: 112 scientists 197–206 publications: 100 scientists 207–216 publications: 89 scientists 217–226 publications: 98 scientists 227–236 publications: 74 scientists 237–246 publications: 72 scientists 247–256 publications: 63 scientists 257–266 publications: 53 scientists 267–276 publications: 54 scientists 277–286 publications: 49 scientists 287–296 publications: 52 scientists 297–306 publications: 43 scientists 307–316 publications: 46 scientists 317–326 publications: 41 scientists 327–336 publications: 42 scientists 337–346 publications: 31 scientists 347–356 publications: 28 scientists 357–366 publications: 29 scientists 367–376 publications: 26 scientists 377–386 publications: 24 scientists 387–396 publications: 24 scientists 397–406 publications: 14 scientists 407–416 publications: 13 scientists 417–426 publications: 20 scientists 427–436 publications: 12 scientists 437–446 publications: 20 scientists 447–456 publications: 11 scientists 457–466 publications: 10 scientists 467–476 publications: 14 scientists 477–486 publications: 14 scientists 487–496 publications: 10 scientists 497–506 publications: 13 scientists 507–516 publications: 13 scientists 517–526 publications: 2 scientists 527–536 publications: 4 scientists 537–546 publications: 6 scientists 547–556 publications: 8 scientists 557–563 publications: 6 scientists 564+ publications: 100 scientists
47 publications 564+

This scientist: 153 publications — 39th percentile

39% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 564 publications or more.

Pulivarthi H. Rao D-index placement in Molecular Biology in 2026

The chart shows the D-index (discipline H-index) distribution of Molecular Biology scientists ranked by Research.com in 2026. The highlighted bar marks where Pulivarthi H. Rao sits on this spectrum.

40–41 D-Index: 36 scientists 42–43 D-Index: 101 scientists 44–45 D-Index: 115 scientists 46–47 D-Index: 121 scientists 48–49 D-Index: 118 scientists 50–51 D-Index: 130 scientists 52–53 D-Index: 106 scientists 54–55 D-Index: 116 scientists 56–57 D-Index: 113 scientists 58–59 D-Index: 129 scientists 60–61 D-Index: 120 scientists 62–63 D-Index: 105 scientists 64–65 D-Index: 131 scientists 66–67 D-Index: 95 scientists 68–69 D-Index: 97 scientists 70–71 D-Index: 106 scientists 72–73 D-Index: 83 scientists 74–75 D-Index: 89 scientists 76–77 D-Index: 77 scientists 78–79 D-Index: 70 scientists 80–81 D-Index: 73 scientists 82–83 D-Index: 60 scientists 84–85 D-Index: 48 scientists 86–87 D-Index: 45 scientists 88–89 D-Index: 50 scientists 90–91 D-Index: 31 scientists 92–93 D-Index: 51 scientists 94–95 D-Index: 43 scientists 96–97 D-Index: 38 scientists 98–99 D-Index: 39 scientists 100–101 D-Index: 41 scientists 102–103 D-Index: 29 scientists 104–105 D-Index: 33 scientists 106–107 D-Index: 35 scientists 108–109 D-Index: 20 scientists 110–111 D-Index: 38 scientists 112–113 D-Index: 19 scientists 114–115 D-Index: 28 scientists 116–117 D-Index: 13 scientists 118–119 D-Index: 23 scientists 120–121 D-Index: 16 scientists 122–123 D-Index: 15 scientists 124–125 D-Index: 11 scientists 126–127 D-Index: 21 scientists 128–129 D-Index: 7 scientists 130–131 D-Index: 13 scientists 132–133 D-Index: 14 scientists 134–135 D-Index: 17 scientists 136–137 D-Index: 9 scientists 138–139 D-Index: 8 scientists 140–141 D-Index: 16 scientists 142–143 D-Index: 7 scientists 144 D-Index: 7 scientists 145+ D-Index: 100 scientists
40 D-Index 145+

This scientist: 65 D-Index — 47th percentile

47% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 145 D-Index or more.

Overview

Pulivarthi H. Rao is affiliated with Baylor College of Medicine in the United States. Their research primarily spans the fields of Medicine and Biochemistry, Genetics and Molecular Biology, with significant contributions in Molecular Biology, Hematology, Oncology, Cellular and Molecular Neuroscience, and Cancer Research.

The scientist's work addresses a variety of topics including Acute Myeloid Leukemia Research, CAR-T cell therapy research, Cancer-related gene regulation, Nuclear Receptors and Signaling, Chromatin Remodeling and Cancer, Cancer-related molecular mechanisms research, and RNA modifications and cancer.

Notable recent papers authored or co-authored by Pulivarthi H. Rao include:

  • Oncogenic Orphan Nuclear Receptor NR4A3 Interacts and Cooperates with MYB in Acinic Cell Carcinoma, 2020, Cancers
  • LncRNA PVT-1 promotes osteosarcoma cancer stem-like properties through direct interaction with TRIM28 and TSC2 ubiquitination, 2022, Oncogene
  • Addressing a Pre-Clinical Pipeline Gap: Development of the Pediatric Acute Myeloid Leukemia Patient-Derived Xenograft Program at Texas Children's Hospital at Baylor College of Medicine, 2024, Biomedicines
  • Frequent detection of CBFA2T3::GLIS2 fusion and RAM-phenotype in pediatric non-Down syndrome acute megakaryoblastic leukemia: a possible novel relationship with aberrant cytoplasmic CD3 expression, 2022, Leukemia & lymphoma/Leukemia and lymphoma
  • Development and characterization of the novel human osteosarcoma cell line COS-33 with sustained activation of the mTOR pathway, 2020, Oncotarget

Frequent co-authors of Rao include:

  • Kevin E. Fisher
  • Andrea N. Marcogliese
  • Amos Gaikwad
  • David Y. Lee
  • Kathryn J. Brayer

Regular publication venues for Rao's work include:

  • Cancers
  • Oncogene
  • Biomedicines
  • Leukemia & lymphoma/Leukemia and lymphoma
  • Oncotarget

Best Publications

  • Dyskeratosis congenita and cancer in mice deficient in ribosomal RNA modification

    Davide Ruggero;Silvia Grisendi;Francesco Piazza;Eduardo Rego;Eduardo Rego

  • Suppression of Myc oncogenic activity by ribosomal protein haploinsufficiency.

    Maria Barna;Aya Pusic;Ornella Zollo;Maria Costa

  • Deregulation of MUM1/IRF4 by chromosomal translocation in multiple myeloma

    Shinsuke Iida;Pulivarthi H. Rao;Marion Butler;Paolo Corradini

  • Chromosomal and gene amplification in diffuse large B-cell lymphoma

    Pulivarthi H. Rao;Jane Houldsworth;Katerina Dyomina;Nasser Z. Parsa

  • Comprehensive analysis of the MYB-NFIB gene fusion in salivary adenoid cystic carcinoma: Incidence, variability, and clinicopathologic significance

    Yoshitsugu Mitani;Jie Li;Pulivarthi H. Rao;Yi Jue Zhao

  • Histopathological, cytogenetic, and molecular characterization of renal cortical tumors.

    Joseph C. Presti;P. H. Rao;Q. Chen;Victor E. Reuter

  • IRTA1 and IRTA2, Novel Immunoglobulin Superfamily Receptors Expressed in B Cells and Involved in Chromosome 1q21 Abnormalities in B Cell Malignancy

    Georgia Hatzivassiliou;Ira Miller;Jun Takizawa;Nallasivam Palanisamy

  • REL proto-oncogene is frequently amplified in extranodal diffuse large cell lymphoma

    Jane Houldsworth;Susan Mathew;Pulivarthi H. Rao;Katerina Dyomina

  • p53 regulates cell survival by inhibiting PIK3CA in squamous cell carcinomas

    Bhuvanesh Singh;Pabbathi G. Reddy;Andy Goberdhan;Christine Walsh

  • The t(9;14)(p13;q32) chromosomal translocation associated with lymphoplasmacytoid lymphoma involves the PAX-5 gene.

    S. Iida;P. H. Rao;P. Nallasivam;H. Hibshoosh

  • Deletions involving two distinct regions of 6q in B-cell non-Hodgkin lymphoma.

    G. Gaidano;R. S. Hauptschein;N. Z. Parsa;K. Offit

  • The presence of p53 mutations in human osteosarcomas correlates with high levels of genomic instability

    Michael Overholtzer;Michael Overholtzer;Pulivarthi H. Rao;Reyna Favis;Xin Yan Lu

  • TP53 loss creates therapeutic vulnerability in colorectal cancer

    Yunhua Liu;Xinna Zhang;Cecil Han;Guohui Wan

  • Genome-wide appraisal of thyroid cancer progression.

    Volkert B. Wreesmann;Ronald A. Ghossein;Snehal G. Patel;Charles P. Harris

  • Novel MYBL1 Gene Rearrangements with Recurrent MYBL1–NFIB Fusions in Salivary Adenoid Cystic Carcinomas Lacking t(6;9) Translocations

    Yoshitsugu Mitani;Bin Liu;Pulivarthi H. Rao;Vishnupriya J. Borra

  • Gene dosage alterations revealed by cDNA microarray analysis in cervical cancer: Identification of candidate amplified and overexpressed genes

    Gopeshwar Narayan;Veronique Bourdon;Seeta Chaganti;Hugo Arias-Pulido

  • Chromosomal amplifications, 3q gain and deletions of 2q33-q37 are the frequent genetic changes in cervical carcinoma

    Pulivarthi H. Rao;Hugo Arias-Pulido;Xin Yan Lu;Charles P. Harris

  • A handcuff model for the cohesin complex

    Nenggang Zhang;Sergey G. Kuznetsov;Shyam K. Sharan;Kaiyi Li

  • Characterization of nonrandom chromosomal gains and losses in multiple myeloma by comparative genomic hybridization.

    Juan C. Cigudosa;Pulivarthi H. Rao;M. Jose Calasanz;M. Dolores Odero

  • Frequent amplification and rearrangement of chromosomal bands 6p12‐p21 and 17p11.2 in osteosarcoma

    Ching C. Lau;Charles P. Harris;Xin Yan Lu;Laszlo Perlaky

Frequent Co-Authors

R. S. K. Chaganti
R. S. K. Chaganti Memorial Sloan Kettering Cancer Center
Ching C. Lau
Ching C. Lau Baylor College of Medicine
Adel K. El-Naggar
Adel K. El-Naggar The University of Texas MD Anderson Cancer Center
Riccardo Dalla-Favera
Riccardo Dalla-Favera Columbia University
Suresh C. Jhanwar
Suresh C. Jhanwar Memorial Sloan Kettering Cancer Center
Bhuvanesh Singh
Bhuvanesh Singh Memorial Sloan Kettering Cancer Center
Richard Gorlick
Richard Gorlick The University of Texas MD Anderson Cancer Center
Randal S. Weber
Randal S. Weber The University of Texas MD Anderson Cancer Center
Jatin P. Shah
Jatin P. Shah Memorial Sloan Kettering Cancer Center
Vundavalli V. Murty
Vundavalli V. Murty Columbia University Medical Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring Molecular Biology doesn’t have to be limited to traditional classroom settings. Numerous related fields offer flexible, online degree options to suit various interests and career goals. For those drawn to the digital communication of science, online graphic design schools can equip you with the tools to visually present scientific ideas.

Students seeking a broader perspective might consider affordable online interdisciplinary studies degrees, which blend biology with subjects like environmental science, psychology, or education. This flexible approach can open up diverse career paths in research, policy, or consulting.

If you’re interested in the historical context of scientific discoveries, pursuing a masters in history online offers valuable insights and research skills applicable to the sciences.

Finally, for those passionate about preserving and sharing knowledge, studying for an affordable library science degree online can lead to careers in science librarianship, archives, or information management settings that support the molecular biology field.

Best Scientists Citing Pulivarthi H. Rao

Trending Scientists

Recently Published Articles